Caspase dependence of target cell damage induced by cytotoxic lymphocytes

Journal of Immunology

Volumn 161, Issue 6, 1998, Pages 2810-2816

  Sarin, Apurva ^a,b   Haddad, Elias K ^a   Henkart, Pierre A ^a,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b TATA INSTITUTE OF FUNDAMENTAL RESEARCH   (India)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; FAS LIGAND; GRANZYME B; PEPTIDE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL NUCLEUS; CYTOTOXIC T LYMPHOCYTE; LEUKEMIA CELL LINE; LYMPHOCYTOTOXICITY; PRIORITY JOURNAL; TARGET CELL;

AMINO ACID CHLOROMETHYL KETONES; ANTIGENS, CD95; APOPTOSIS; CELL MEMBRANE; CELL NUCLEUS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; CYTOPLASMIC GRANULES; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; EXOCYTOSIS; FAS LIGAND PROTEIN; HUMANS; JURKAT CELLS; KILLER CELLS, NATURAL; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LIGANDS; MEMBRANE GLYCOPROTEINS; MITOCHONDRIA; OLIGOPEPTIDES; PHOSPHATIDYLSERINES; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0032530361     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Henkart, P. A. 1994. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1:343.
2. Lanier, L. L., B. Corliss, and J. H. Phillips. 1997. Arousal and inhibition of human NK cells. Immunol. Rev. 155:145.
3. Henkart, P. A., M. S. Williams, and H. Nakajima. 1995. Degranulating cytotoxic lymphocytes inflict multiple damage pathways on target cells: a cytolysin/perforin-mediated membrane damage pathway and a granzyme-mediated internal disintegration pathway. Curr. Top. Microbiol. Immunol. 198:75.
4. Kägi, D., B. Ledermann, K. Bürki, R. M. Zinkernagel, and H. Hengartner. 1996. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14:207.
5. Russell, J. H. 1983, Internal disintegration model of cytotoxic lymphocyte-induced target damage. Immunol. Rev. 72:97.
6. Henkart, P. A., M. S. Williams, C. M. Zacharchuk, and A. Sarin. 1997. Do CTL kill target cells by inducing apoptosis? Semin. Immunol. 9:135.
7. Nicholson, D. W., and N. A. Thomberry. 1997. Caspases: killer proteases. Trends Biochem. Sci. 22:299.
8. Villa, P., S. H. Kaufmann, and W. C. Earnshaw. 1997. Caspases and caspase inhibitors. Trends Biochem. Sci. 22:388.
9. Chinnaiyan, A. M., K. O'Rourke, M. Tewari, and V. M. Dixit. 1995. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81:505.
10. Sarin, A., M. S. Williams, M. A. Alexander-Miller, J. A. Berzofsky, C. M. Zacharchuk, and P. A. Henkart. 1997. Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases. Immunity 6:209.
11. Thornberry, N. A., T. A. Rano, E. P. Peterson, D. M. Rasper, T. Timkey, M. Garcia-Calvo, V. M. Houtzager, P. A. Nordstrom, S. Roy, J. P. Vaillancourt, K. T. Chapman, and D. W. Nicholson. 1997. A combinatorial approach defines specificities of members of the caspase family and granzyme B: functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272:17907.
12. Talanian, R. V., X. Yang, J. Turbov, P. Seth, T. Ghayur, C. A. Casiano, K. Orth, and C. J. Froelich. 1997. Granule-mediated killing: pathways for granzyme B-initiated apoptosis. J. Exp. Med. 186:1323.
13. Darmon, A. J., D. W. Nicholson, and R. C. Bleackley. 1995. Activation of the apoptotic protease CPP32 by cytotoxic T cell-derived granzyme B. Nature 377: 446.
14. Shi, L., C. M. Kam, J. C. Powers, R. Aebersold, and A. H. Greenberg. 1992. Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions. J. Exp. Med. 176:1521.
15. Shresta, S., J. H. Russell, and T. J. Ley. 1997. Mechanisms responsible for granzyme B-independent cytotoxicity. Blood 89:4085.
16. Shresta, S., D. M. Maclvor, J. W. Heusel, J. H. Russell, and T. J. Ley. 1995. Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells. Proc. Natl. Acad. Sci. USA 92:5679.
17. Perez, P., R. W. Hoffman, S. Shaw, J. A. Bluestone, and D. M. Segal. 1985. Specific targeting of CTL by anti-T3 linked to anti-target cell antibody. Nature 316:354.
18. Castedo, M., A. Macho, N. Zamzami, T. Hirsch, P. Marchetti, J. Uriel, and G. Kroemer. 1995. Mitochondrial perturbations define lymphocytes undergoing apoptotic depletion in vivo. Eur. J. Immunol. 25:3277.
19. Roger, R., C. Issaad, M. Pallardy, M. C. Leglise, A. G. Turhan, J. Bertoglio, and J. Breard. 1996. BCR-ABL does not prevent apoptotic death induced by human natural killer or lymphokine-activated killer cells. Blood 87:1113.
20. Sarin, A., M.-L. Wu, and P. A. Henkart. 1996. Different ICE-family protease requirements for the apoptotic death of T lymphocytes triggered by diverse stimuli. J. Exp. Med. 184:2445.
21. 2+-independent T cell-mediated cytotoxicity. J. Exp. Med. 177:195.
22. Martin, S. J., D. M. Finucane, G. P. Amarante-Mendes, G. A. O'Brien, and D. R. Green. 1996. Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. J. Biol. Chem. 271:28753.
23. Vanags, D. M., M. I. Porn-Ares, S. Coppola, D. H. Burgess, and S. Orrenius. 1996. Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J. Biol. Chem. 271:31075.
24. Zamzami, N., P. Marchetti, M. Castedo, C. Zanin, J. L. Vayssière, P. X. Petit, and G. Kroemer. 1995. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181:1661.
25. Sanderson, C. J. 1976. The mechanism of T cell mediated cytotoxicity. II. Morphological studies of cell death by time-lapse microcinematography. Proc. R. Soc. London 192:241.
26. Hahn, K., R. DeBiasio, A. Tishon, H. Lewicki, J. E. Gairin, G. LaRocca, D. L. Taylor, and M. Oldstone. 1994. Antigen presentation and cytotoxic T lymphocyte killing studied in individual, living cells. Virology 201:330.
27. Duvall, E., and A. H. Wyllie. 1986. Death and the cell. Immunol. Today 7:115.
28. Kawasaki, Y., T. Saito, Y. Shirota-Someya, and H. Takayama. 1997. Membrane perturbation as an early event in the target cell induced by CTL attack. In EMBO Workshop on Cell-Mediated Cytotoxicity, Kerkrade, The Netherlands, April 5 to 9, 1997, p. 71.
29. Betz, W. J., F. Mao, and G. S. Bewick. 1992. Activity-dependent fluorescent staining and destaining of living vertebrate motor nerve terminals. J. Neurosci. 12:363.
30. Betz, W. J., F. Mao, and C. B. Smith. 1996. Imaging exocytosis and endocytosis. Curr. Opin. Neurobiol. 6:365.
31. Enari, M., H. Sakahira, H. Yokoyama, K. Okawa, A. Iwamatsu, and S. Nagata. 1998. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391:43.
32. Nakajima, H., P. Golstein, and P. A. Henkart. 1995. The target cell nucleus is not required for cell-mediated granzyme- or Fas-based cytotoxicity. J. Exp. Med. 181:1905.
33. Nakajima, H., H. L. Park, and P. A. Henkart. 1995. Synergistic roles of granzymes A and B in mediating target cell death by RBL mast cell tumors also expressing cytolysin/perforin. J. Exp. Med. 181:1037.
34. Bump, N. J., M. Hackett, M. Hugunin, S. Seshagiri, K. Brady, P. Chen, C. Ferenz, S. Franklin, T. Ghayur, P. Li, P. Licari, J. Mankovich, L. Shi, A. H. Greenberg, L. K. Miller, and W. W. Wong. 1995. Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science 269:1885.
35. Sarin, A., K. Ebnet, C. M. Zacharchuk, and P. A. Henkart. 1997. Caspase inhibitors as molecular probes of cell death. In Programmed Cell Death: Proceedings of the 1996 International Symposium on Programmed Cell Death in Shanghai. Y.-B. Shi, Y. Shi, D. W. Scott, and Y. Xu, eds. Plenum Press, New York, p. 51.
36. McCarthy, N. J., M. K. Whyte, C. S. Gilbert, and G. I. Evan. 1997. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J. Cell Biol. 136:215.
37. Monney, L., I. Otter, R. Olivier, H. L. Ozer, A. L. Haas, S. Omura, and C. Borner. 1998. Defects in the ubiquitin pathway induce caspase-independent apoptosis blocked by Bcl-2. J. Biol. Chem. 273:6121.
38. Xiang, J., D. T. Chao, and S. J. Korsmeyer. 1996. BAX-induced cell death may not require interleukin 1 β-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA 93:14559.
39. Lavoie, J. N., M. Nguyen, R. C. Marcellus, P. E. Branton, and G. C. Shore. 1998. E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by zVAD-fmk. J. Cell Biol. 140:637.
40. Savill, J., V. Fadok, P. Henson, and C. Haslett. 1993. Phagocyte recognition of cells undergoing apoptosis. Immunol. Today 14:131.
41. Martin, S. J., C. P. M. Reutelingsperger, A. J. McGahon, J. A. Rader, R. C. A. A. van Schie, D. M. LaFace, and D. R. Green. 1995. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Ab1. J. Exp. Med. 182:1545.
42. Hampton, M. B., D. M. Vanags, M. I. Porn-Ares, and S. Orrenius. 1996. Involvement of extracellular calcium in phosphatidylserine exposure during apoptosis. FEBS Lett. 399:277.
43. Bratton, D. L., V. A. Fadok, D. A. Richter, J. M. Kailey, L. A. Guthrie, and P. M. Henson. 1997. Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase. J. Biol. Chem. 272:26159.
44. McConkey, D. J., and S. Orrenius. 1997. The role of calcium in the regulation of apoptosis. Biochem. Biophys. Res. Commun. 239:357.
45. Zwaal, R. F. A., and A. J. Schroit. 1997. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89:1121.
46. Hirsch, T., P. Marchetti, S. A. Susin, B. Dallaporta, N. Zamzami, I. Marzo, M. Geuskens, and G. Kroemer. 1997. The apoptosis-necrosis paradox: apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 15:1573.
47. Susin, S. A., N. Zamzami, M. Castedo, E. Daugas, H. G. Wang, S. Geley, F. Fassy, J. C. Reed, and G. Kroemer. 1997. The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95-and ceramide-induced apoptosis. J. Exp. Med. 186:25.
48. Krippner, A., A. Matsuno-Yagi, R. A. Gottlieb, and B. M. Babior. 1996. Loss of function of cytochrome c in Jurkat cells undergoing Fas-mediated apoptosis. J. Biol. Chem. 271:21629.
49. Bossy, W., E., D. D. Newmeyer, and D. R. Green. 1998. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J. 17:37.
50. Li, F., A. Srinivasan, Y. Wang, R. C. Armstrong, K. J. Tomaselli, and L. C. Fritz. 1997. Cell-specific induction of apoptosis by microinjection of cytochrome c. J. Biol. Chem. 272:30299.
51. Li, P., D. Nijhawan, I. Budihardjo, S. M. Srinivasula, M. Ahmad, E. S. Alnemri, and X. Wang. 1997. Cytochrome c and dATP-dependent formation of Apaf-1/ caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479.